Compounds > satavaptan
Page last updated: 2024-09-04

satavaptan and Hypovolemia

satavaptan has been researched along with Hypovolemia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kilonzo, K; Lee, JJ; Nistico, A; Yeates, K1
Dabrowska, MD; Krysiak, R; Okopień, B1
Ghali, JK1

Reviews

3 review(s) available for satavaptan and Hypovolemia

ArticleYear
Management of hyponatremia.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2014, May-13, Volume: 186, Issue:8

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Disease Management; Female; Humans; Hyponatremia; Hypovolemia; Inappropriate ADH Syndrome; Male; Morpholines; Prognosis; Pyrroles; Receptors, Vasopressin; Risk Assessment; Severity of Illness Index; Spiro Compounds; Tolvaptan; Treatment Outcome

2014
[Hyponatremic hypervolemia in heart failure--the hot spot for vasopressin receptor antagonists?].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2012, Volume: 65, Issue:1

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Diuretics; Heart Failure; Humans; Hyponatremia; Hypovolemia; Morpholines; Pyrroles; Spiro Compounds; Tolvaptan

2012
Mechanisms, risks, and new treatment options for hyponatremia.
    Cardiology, 2008, Volume: 111, Issue:3

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Diuretics; Heart Failure; Hospitalization; Humans; Hyponatremia; Hypovolemia; Morpholines; Prognosis; Risk Factors; Saline Solution, Hypertonic; Spiro Compounds

2008